TY - JOUR
T1 - Survey of clinical practice for irritable bowel syndrome in east asian countries the international gastrointestinal consensus symposium study group
AU - Fukudo, Shin
AU - Hahm, Ki Baik
AU - Zhu, Qi
AU - Sollano, Jose D.
AU - Rani, Abdul A.
AU - Syam, Ari F.
AU - Kachintorn, Udom
AU - Suzuki, Hidekazu
AU - Kamiya, Takeshi
AU - Joh, Takashi
AU - Uchiyama, Kazuhiko
AU - Naito, Yuji
AU - Takahashi, Shin'Ichi
AU - Kinoshita, Yoshikazu
AU - Ueno, Fumiaki
AU - Yamagami, Hirokazu
AU - Chan, Francis K.L.
AU - Fock, Kwong M.
AU - Arakawa, Tetsuo
N1 - Publisher Copyright:
© 2015 S. Karger AG, Basel.
PY - 2015/2/6
Y1 - 2015/2/6
N2 - Aim: Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues towards solving this problem. The aims of this study were to depict the clinical realities of IBS in East Asian countries and test the hypothesis that the diagnosis and treatment of IBS differ between countries. Subjects and Methods: Study participants were 251 physicians involved in the clinical practice of IBS at major institutions in Japan, South Korea, China, the Philippines, Indonesia and Singapore. The questionnaire contained 45 questions focused on the clinical practice of IBS. Results: Subjects in Japan, South Korea, China, Indonesia, the Philippines and Singapore accounted for 55.4, 17.9, 8.8, 8.0, 6.4 and 3.6% of the study cohort, respectively. Amongst East Asian physicians, the most important symptom was considered to be abdominal pain by 33.4%, whilst 24.3% regarded alternating diarrhea and constipation to be the most important symptoms. Total colonoscopy and histopathology use showed no difference among countries. Prescriptions given for mild (p < 0.0001), moderate (p < 0.0001), severe (p < 0.0001), intractable (p = 0.002), diarrheal (p < 0.0001) and constipating (p < 0.0001) patients with IBS significantly differed between the countries. Except for several minor points, IBS specialists showed no significant difference in their diagnosis and treatment of IBS when compared to nonspecialists. Conclusion: This survey provided data on the clinical treatment of IBS among East Asian countries. The results supported the hypothesis that the diagnosis and treatment of IBS differs between countries.
AB - Aim: Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues towards solving this problem. The aims of this study were to depict the clinical realities of IBS in East Asian countries and test the hypothesis that the diagnosis and treatment of IBS differ between countries. Subjects and Methods: Study participants were 251 physicians involved in the clinical practice of IBS at major institutions in Japan, South Korea, China, the Philippines, Indonesia and Singapore. The questionnaire contained 45 questions focused on the clinical practice of IBS. Results: Subjects in Japan, South Korea, China, Indonesia, the Philippines and Singapore accounted for 55.4, 17.9, 8.8, 8.0, 6.4 and 3.6% of the study cohort, respectively. Amongst East Asian physicians, the most important symptom was considered to be abdominal pain by 33.4%, whilst 24.3% regarded alternating diarrhea and constipation to be the most important symptoms. Total colonoscopy and histopathology use showed no difference among countries. Prescriptions given for mild (p < 0.0001), moderate (p < 0.0001), severe (p < 0.0001), intractable (p = 0.002), diarrheal (p < 0.0001) and constipating (p < 0.0001) patients with IBS significantly differed between the countries. Except for several minor points, IBS specialists showed no significant difference in their diagnosis and treatment of IBS when compared to nonspecialists. Conclusion: This survey provided data on the clinical treatment of IBS among East Asian countries. The results supported the hypothesis that the diagnosis and treatment of IBS differs between countries.
KW - East Asian countries
KW - Functional gastrointestinal disorders
KW - Irritable bowel syndrome
KW - Rome III criteria
UR - http://www.scopus.com/inward/record.url?scp=84922287190&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84922287190&partnerID=8YFLogxK
U2 - 10.1159/000369078
DO - 10.1159/000369078
M3 - Article
C2 - 25632923
AN - SCOPUS:84922287190
SN - 0012-2823
VL - 91
SP - 99
EP - 109
JO - Digestion
JF - Digestion
IS - 1
ER -